Chinese Firms Ordered To Pay Pfizer Unit $57.5 Million In Spy Case
This article was originally published in PharmAsia News
Executive Summary
A county judge in North Carolina ruled in favor of the state's Serenex biopharmaceutical company in a suit against China's Beijing Gylongli Science and Technology and GYLL Biomedtech. The Serenex suit said the people from the two companies engaged in corporate espionage against the U.S. firm and stole trade secrets. A Wake County judge ordered the Chinese companies and Tongxiang Zhang, operator of both companies, to pay Serenex $57.5 million in damages. Serenex, acquired by Pfizer earlier this year, sued after Zhang and others applied for a patent for a drug similar to the Serenex drug. None of the Chinese parties to the suit responded legally to the filing of the suit. (Click here for more
You may also be interested in...
Investors Go Berserk For Viking, Putting It Top Of Q1 Winners
The top 10 biggest share price winners and losers in Q1 from Evaluate show the investor frenzy for obesity drugs continues, while companies with governance doubts see shareholders retreat.
EU Consults On What Constitutes Personal & Commercially Confidential Data In Marketing Applications
Based on their experience with dealing with requests for access to documents over the past 12 years, EU regulators have proposed updating their guideline that provides for a harmonized approach to protecting personal data and business secrets in marketing authorization applications.
Industry & Regulators To Align Advice on COVID-19 Vaccine Updates
A multi-stakeholder workshop looked at the data needed to support updates to vaccine composition and the time required by manufacturers to update their vaccines, change their manufacturing processes and prepare approval applications.